Skip to main content

Table 2 Summary of average ± s.d. doses to PTVs and OAR for the 20 patients in Set_2

From: Effectiveness of Multi-Criteria Optimization-based Trade-Off exploration in combination with RapidPlan for head & neck radiotherapy planning

Structure

Parameter

a - Clinical

b - Clinical + TO

c - RP_1

d - RP_1 + TO

e - RP_TO

f - RP_ TO+

PTV 1

D99% > 90%

p < 0.05

93.7 ± 0.9

c

94.1 ± 2.0

94.2 ± 1.2

a,e

93.8 ± 2.5

93.6 ± 1.5

c

93.7 ± 2.3

D95% > 95%

p < 0.05

96.1 ± 0.6

b,c,d

96.8 ± 0.8

a,c,e,f

96.3 ± 0.7

a,b,e

96.6 ± 1.0

a,e

96.0 ± 0.9

b,c,d,f

96.4 ± 0.9

b,e

D5% < 105%

p < 0.05

102.9 ± 0.5

b,d

102.4 ± 0.5

a,c,e,f

102.7 ± 0.4

b,d,e

102.4 ± 0.7

a,c,e,f

103.1 ± 0.6

b,c,d,

102.8 ± 0.8

b,d,

D2% < 107%

p < 0.05

103.5 ± 0.7

b,d,e

103.0 ± 0.8

a,c,e,f

103.4 ± 0.6

b,e

103.5 ± 0.9

a,e,f

103.8 ± 0.8

a,b,c,d

103.7 ± 1.2

b,d

HI

p < 0.05

1.07 ± 0.01

b,c,d

1.06 ± 0.01

a,c,e,f

1.07 ± 0.01

a,b,d,e

1.06 ± 0.02

a,e,f

1.07 ± 0.01

b,c,d,f

1.07 ± 0.02

b,d,e

PTV LR

D99% > 74.8%

p < 0.05

77.4 ± 0.6

c,f

77.1 ± 1.0

c,f

78.4 ± 0.7

a,b,d,e,f

77.0 ± 1.4

c,f

77.5 ± 1.0

c,f

76.0 ± 1.2

a,b,c,d,e

D95% > 78.9%

p < 0.05

79.7 ± 0.4

b,c,d,f

81.1 ± 0.9

a,c,e

80.2 ± 0.5

a,b,d,e,f

81.2 ± 0.6

a,c,e

79.9 ± 0.6

b,c,d,f

80.8 ± 0.9

a,c,e

HI

p < 0.05

1.13 ± 0.02

b,c,d,f

1.16 ± 0.02

a,c,e,f

1.12 ± 0.01

a,b,d,e,f

1.16 ± 0.02

a,c,e,f

1.13 ± 0.01

b,c,d,f

1.17 ± 0.02

a,b,c,d,e

PRV Brainstem

DMax < 48Gy

p < 0.05

26.9 ± 15.7

b,c,d,e,f

24.3 ± 14.5

a,f

25.9 ± 14.8

a,d,e,f

23.2 ± 13.3

a, c,

23.9 ± 13.5

a,c,f

20.9 ± 11.6

a,b,c,e

PRV Spinal Cord

D1% < 44Gy

p < 0.05

37.6 ± 2.7

b,c,d,e,f

32.7 ± 2.9

a,c,d,f

36.4 ± 2.2

a,b,d,e,f

30.5 ± 3.1

a,b,c,f

31.5 ± 3.0

a,c,f

27.5 ± 4.7

a,b,c,d,e

DMax < 48Gy

p < 0.05

40.4 ± 2.9

b,d,e,f

35.1 ± 2.9

a,c,f

39.3 ± 2.2

b,d,e,f

33.6 ± 3.4

a,c,f

34.3 ± 3.5

a,c,f

30.8 ± 4.9

a,b,c,d,e

Left Parotid

DMean < 24Gy

p < 0.05

22.9 ± 5.5

b,d,e,f

16.7 ± 4.8

a,c,f

22.3 ± 5.5

b,d,e,f

16.7 ± 4.5

a,c,f

16.8 ± 4.9

a,c,f

15.0 ± 4.6

a,b,c,d,e

Right Parotid

DMean < 24Gy

p < 0.05

24.8 ± 5.8

b,d,e,f

19.1 ± 4.4

a,c,f

24.2 ± 5.4

b,d,e,f

18.4 ± 4.7

a,c,f

19.0 ± 5.9

a,c,f

17.1 ± 5.0

a,b,c,d,e

CI

V100%/VPTVs

p < 0.05

0.27 ± 0.08

b,d,

0.29 ± 0.09

a,c,e

0.27 ± 0.08

b,d,f

0.29 ± 0.09

a,c

0.28 ± 0.09

b,

0.29 ± 0.09

c,

V80%/VPTVs

p < 0.05

1.26 ± 0.14

b,d,f

1.47 ± 0.15

a,c,d,e,f

1.23 ± 0.06

b,d,f

1.40 ± 0.08

a,b,c,e

1.24 ± 0.06

b,d,f

1.41 ± 0.07

a,b,c,e

V50%/VPTVs

p < 0.05

2.55 ± 0.33

b,d,f

2.94 ± 0.41

a,c,d,e,f

2.49 ± 0.19

b,d,e,f

2.79 ± 0.25

a,b,c,e

2.52 ± 0.21

b,c,d,f

2.84 ± 0.29

a,b,c,e

V10%/VPTVs

p < 0.05

9.31 ± 1.89

b,d,f

9.55 ± 1.90

a,c,d,e,f

9.28 ± 1.84

b,d,f

9.41 ± 1.81

a,b,c,e

9.28 ± 1.81

b,d,f

9.39 ± 1.78

a,b,c,e

Right Parotid

DMean < 24Gy

p < 0.05

24.8 ± 5.8

b,d,e,f

19.1 ± 4.4

a,c,f

24.2 ± 5.4

b,d,e,f

18.4 ± 4.7

a,c,f

19.0 ± 5.9

a,c,f

17.1 ± 5.0

a,b,c,d,e

Total Fails

Parameters

22

2

20

4

11

3

Plans

13

2

13

3

7

2

  1. Comparisons are based on the Wilcoxon signed-rank test and significant differences (p-value < 0.05) between planning methods are indicated with the letters. The last two rows show the number of plans in each group that failed to meet all the constraints and the number of parameters that were violated within them